Eastwood Bio-Medical Canada Inc. (EBM.V)
CAD 0.41
(-2.38%)
CAD 0.41
(-2.38%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.32 Million CAD | 51.35% |
| 2022 | 878.73 Thousand CAD | 5.18% |
| 2021 | 835.44 Thousand CAD | 76.21% |
| 2020 | 474.1 Thousand CAD | 41.22% |
| 2019 | 335.73 Thousand CAD | -7.11% |
| 2018 | 361.41 Thousand CAD | 548.22% |
| 2017 | 55.75 Thousand CAD | 56.77% |
| 2016 | 35.56 Thousand CAD | -63.74% |
| 2015 | 98.08 Thousand CAD | 9.98% |
| 2014 | 89.18 Thousand CAD | -97.72% |
| 2013 | 3.91 Million CAD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 1.38 Million CAD | 7.18% |
| 2024 Q3 | 1.47 Million CAD | 6.36% |
| 2024 Q1 | 1.29 Million CAD | -2.9% |
| 2023 Q4 | 1.32 Million CAD | 16.69% |
| 2023 Q3 | 1.13 Million CAD | 8.27% |
| 2023 FY | 1.32 Million CAD | 51.35% |
| 2023 Q1 | 869.98 Thousand CAD | -1.0% |
| 2023 Q2 | 1.05 Million CAD | 21.0% |
| 2022 Q3 | 955.09 Thousand CAD | 9.01% |
| 2022 Q4 | 878.73 Thousand CAD | -8.0% |
| 2022 FY | 878.73 Thousand CAD | 5.18% |
| 2022 Q1 | 812.63 Thousand CAD | -2.73% |
| 2022 Q2 | 876.14 Thousand CAD | 7.82% |
| 2021 Q4 | 835.44 Thousand CAD | -12.44% |
| 2021 FY | 835.44 Thousand CAD | 76.21% |
| 2021 Q2 | 799.99 Thousand CAD | 29.7% |
| 2021 Q1 | 616.81 Thousand CAD | 30.1% |
| 2021 Q3 | 954.16 Thousand CAD | 19.27% |
| 2020 Q4 | 474.1 Thousand CAD | 78.72% |
| 2020 FY | 474.1 Thousand CAD | 41.22% |
| 2020 Q3 | 265.28 Thousand CAD | -12.58% |
| 2020 Q2 | 303.46 Thousand CAD | -17.58% |
| 2020 Q1 | 368.2 Thousand CAD | 9.67% |
| 2019 Q4 | 335.73 Thousand CAD | -23.6% |
| 2019 FY | 335.73 Thousand CAD | -7.11% |
| 2019 Q1 | 350.93 Thousand CAD | -2.9% |
| 2019 Q2 | 462.46 Thousand CAD | 31.78% |
| 2019 Q3 | 439.46 Thousand CAD | -4.97% |
| 2018 Q4 | 361.41 Thousand CAD | 193.03% |
| 2018 FY | 361.41 Thousand CAD | 548.22% |
| 2018 Q1 | 26.65 Thousand CAD | -52.2% |
| 2018 Q2 | 85.07 Thousand CAD | 219.23% |
| 2018 Q3 | 123.33 Thousand CAD | 44.97% |
| 2017 Q3 | 41.65 Thousand CAD | -11.64% |
| 2017 Q4 | 55.75 Thousand CAD | 33.87% |
| 2017 Q1 | 67.58 Thousand CAD | 90.02% |
| 2017 Q2 | 47.13 Thousand CAD | -30.25% |
| 2017 FY | 55.75 Thousand CAD | 56.77% |
| 2016 Q1 | 52.43 Thousand CAD | -46.54% |
| 2016 Q2 | 21.52 Thousand CAD | -58.94% |
| 2016 Q4 | 35.56 Thousand CAD | 19.16% |
| 2016 Q3 | 29.84 Thousand CAD | 38.63% |
| 2016 FY | 35.56 Thousand CAD | -63.74% |
| 2015 Q3 | 14.55 Thousand CAD | 3.87% |
| 2015 Q4 | 98.08 Thousand CAD | 573.8% |
| 2015 Q2 | 14.01 Thousand CAD | -94.73% |
| 2015 Q1 | 266.07 Thousand CAD | 198.32% |
| 2015 FY | 98.08 Thousand CAD | 9.98% |
| 2014 Q4 | 89.18 Thousand CAD | -82.29% |
| 2014 FY | 89.18 Thousand CAD | -97.72% |
| 2014 Q3 | 503.73 Thousand CAD | 0.0% |
| 2013 Q3 | 3.91 Million CAD | 0.0% |
| 2013 Q4 | 3.91 Million CAD | 0.0% |
| 2013 FY | 3.91 Million CAD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|